Countdown to 2021 CBIIC：
Founding Partner of Shenzhen Qianhai YuanMing Asset Management Co., Ltd
Dr. Lawrence Tian is a Founding Partner of YuanMing Capital. YuanMing Capital focuses on the investment in pharmaceutial research and development, innovative medical devices and high-end medical services in both China and the United States. YuanMing has successfully invested in a dozen of leading biopharma companies including BeiGene, Ascentage Pharma, Mevion Medical Systems, Pharmacodia, CF PharmTech, JW Theraperutics, Adlai Nortye and Digital China Health.
Prior to founding YuanMing Capital, Dr. Tian established China International Futures Corporation, co-founded Wu Mart Supermarket and Yabuli Ski Resort. He also served as Chairman of China Chengtong Group. Since 2010, Dr. Tian has been committed to promoting China’s capital investment into US life science innovative companies, and has accumulated solid experiences and an outstanding track record.
Dr. Tian is the Founder and Chairman of China Entrepreneurs Forum and China-U.S. Business Leaders Roundtable. As a core organizer of various high-end meeting for entrepreneurs of both countries, Dr. Tian is an influential figure in the Sino-China business scene and has extensive social influence. He serves as the Chairman of Investment Committee of China Pharmaceutical Industry Research and Development Association, and he is a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited (“HKEX”). Dr. Tian obtained his master’s degree and doctoral degree from Wuhan University. He was the recipient of China’s highest prize for economics: China Economics Theory Innovation Award.